Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Change in inspiratory peak flow after bronchodilation in moderate to severe COPD
2006-000511-26Phase 4Active
- Sponsor
- Universitätsmedizin Mainz - Pneumologie
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Universitätsmedizin Mainz - Pneumologie. Primary endpoint: Therapy control with bronchodilator based on inspiratory peak flow. Started Aug 2006; status: active.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-000511-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000511-26.